Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2010
12/29/2010CN101928335A Fungus antitumor polypeptide nucleotide sequence, and preparation method and applications thereof
12/29/2010CN101928288A Small molecule compositions for binding to HSP90
12/29/2010CN101927012A Virus inactivating method for nerve growth factors
12/29/2010CN101926988A Injectable vaccines against multiple meningococcal serogroups
12/29/2010CN101565703B Eriocheir sinensis Crustin-2 gene and application of recombinant protein thereof
12/29/2010CN101160413B Kit for detecting the antibody of HCV and its detecting method
12/29/2010CN101113424B Coleoptera pest efficient Bacillus thuringiensis cry8G gene, protein and uses thereof
12/29/2010CN101054412B Pathogenic gene for far end arthrosis bend, detection method and application thereof
12/29/2010CN101054411B Corn calcium adjusting phosphatase B analogy albumen, coding gene and application thereof
12/29/2010CN101031647B Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
12/29/2010CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010CA2768172A1 Novel compositions
12/29/2010CA2766349A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives
12/29/2010CA2766272A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery
12/29/2010CA2766211A1 Recombinant rsv antigens
12/29/2010CA2766205A1 Vaccine
12/29/2010CA2766040A1 Process for production of peptide thioester
12/29/2010CA2765889A1 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
12/29/2010CA2765833A1 Modified biotin-binding protein
12/29/2010CA2765727A1 Stabilizing alkylglycoside compositions and methods thereof
12/29/2010CA2765108A1 Truncated actriib-fc fusion proteins
12/29/2010CA2764860A1 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof
12/29/2010CA2764649A1 Multimeric polypeptides of hla-g including alpha1-alpha3 monomers and pharmaceutical uses thereof
12/29/2010CA2764131A1 Antimicrobial agents
12/28/2010US7858854 Plants and seed of inbred corn variety DS-046358
12/28/2010US7858847 Protein kinase stress-related proteins and methods of use in plants
12/28/2010US7858846 introducing into proginator cells of the plant a plant transformation vector containing a nucleotide sequence that encodes or is complementary to a sequence that encodes a High Oil polypeptide; transgenic plants; seed oil
12/28/2010US7858845 Sugar and lipid metabolism regulators in plants IV
12/28/2010US7858844 Non-human transgenic organism comprising transgene coding non-aggregating chromo- or fluorescent Cnidarian chromo- or fluorescent protein; chemiluminescent labels and molecular biology
12/28/2010US7858767 Regulatory sequences useful for production of plants with modified embryo and/or endosperm development
12/28/2010US7858766 Nucleotide sequences coding HEV (hemorrhagic enteritis virus) or EDS (egg drop syndrome virus) capsid proteins for use in vaccinating domestic birds against pathogenic adenoviral infection
12/28/2010US7858765 OX40R binding agents
12/28/2010US7858762 Expression vector comprising nucleotide sequences coding osmosensitive (os-6) protein for use as tool in enhancing propagation in transgenic bacillus
12/28/2010US7858760 Antibodies to protein expressed in prostate cancer
12/28/2010US7858757 Immunoglobulin for detecting fetal red blood cells in maternal blood; diagnosing chromosomal or genetic defects in developing fetus
12/28/2010US7858755 Monoclonal antibodies that bind Chemerin polypeptide
12/28/2010US7858754 Nel-related protein type 1 antibody
12/28/2010US7858751 Peptide fragment of LYVE-1 and antibody against the same
12/28/2010US7858750 Antibodies to tumor associated proteins
12/28/2010US7858746 recognize selectively both Programmed Death 1 (PD-1) protein and a membrane protein co-existing with PD-1 on a cell membrane, and can transmit a suppressive signal of PD-1; for medical treatment and/or prevention of diseases caused by immune abnormality
12/28/2010US7858745 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells
12/28/2010US7858744 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance
12/28/2010US7858742 Lymphoma associated molecules and uses therefor
12/28/2010US7858739 Inhibitors of type 2 vascular endothelial growth factor receptors
12/28/2010US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/28/2010US7858737 Heterogeneous foldamers containing α, β, and/or γ-amino acids
12/28/2010US7858679 Polymeric compositions and related methods of use
12/28/2010US7858584 Angiogenically effective unit dose of FGF and method of administering
12/28/2010US7858576 Method for targeting lysosomal enzymes
12/28/2010US7858399 Activating the carboxyl group on an optionally protected amino-substituted benzoic acid and reacting the product with a polyamine; the product may then be reacted with an oxyalkylenediamine derivative and binding the product to a latex polymer via aliphatic amine groups
12/28/2010US7858361 Commercialization of LK8 protein as a novel angiogenesis inhibitor; culturing
12/28/2010US7858357 Immunization with bacterial ghost-based vaccines
12/28/2010US7858356 Mutant paramyxovirus and method for production thereof
12/28/2010US7858346 Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein
12/28/2010US7858345 Of given amino acid sequence; use in diagnosis and treatment of enzootic pneumonia in swine; kits
12/28/2010US7858344 Compositions of aminoacyl-tRNA synthetase and uses thereof
12/28/2010US7858341 using an E. coli expression system for the large scale production of FGF18 (fibroblast growth factors); improved methods for producing biologically active and purified recombinant FGF18
12/28/2010US7858339 Refractile particles containing a heterologous polypeptide as an insoluble aggregate are recovered from bacterial periplasm; allows use of phage lysozyme at high cell density and increased scale; Chloroform is not used in any step and the recovery step minimizes co-recovery of cellular debris
12/28/2010US7858326 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function
12/28/2010US7858325 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
12/28/2010US7858322 Method of determining inhibition of binding to TRPM7 protein
12/28/2010US7858312 Method of treating bladder and lower urinary tract syndromes
12/28/2010US7858300 Methods and compositions to evaluate antibody treatment response
12/28/2010US7858299 bacteriophage tail proteins capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+
12/28/2010US7858297 Chemokine-binding protein and methods of use
12/28/2010US7858103 Characterizing inflammatory mediator for use in generating antibodies for prevention and treatment of helicobacter infection; immunotherapy
12/28/2010US7858099 Method for inducing an immunological response in an animal
12/28/2010US7858096 Mutant forms of meningococcal ADP-ribosylating toxin
12/28/2010US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
12/28/2010US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
12/28/2010US7858090 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
12/28/2010US7858082 providing a bulk of monomeric protein in a buffer solution and adding an excipient selected from bacteriostatic agents, surfactants, isotonicity agents, amino acids, antioxidants and combinations thereof; refereably the monomeric protein is IFN-beta
12/28/2010US7858081 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69
12/23/2010WO2010148234A1 Sap variants and their use
12/23/2010WO2010148142A1 Chimeric fgf19 polypeptides and uses thereof
12/23/2010WO2010148128A1 Beta-glucosidase variant enzymes and related polynucleotides
12/23/2010WO2010148089A1 Gip receptor-active glucagon compounds
12/23/2010WO2010148010A1 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularih 1 (mtm1) polypeptides
12/23/2010WO2010147904A1 Improved optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
12/23/2010WO2010147880A2 Dig-11 insecticidal cry toxins
12/23/2010WO2010147879A1 Dig-10 insecticidal cry toxins
12/23/2010WO2010147877A1 Dig-5 insecticidal cry toxins
12/23/2010WO2010147803A2 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes
12/23/2010WO2010147642A1 Production of triacylglycerides, fatty acids, and their derivatives
12/23/2010WO2010147117A1 Peptide and use thereof
12/23/2010WO2010147109A1 Angiogenesis inducer comprising genetically modified gelatin and basic fibroblast growth factor
12/23/2010WO2010146848A1 An antigenic peptide derived from influenza virus and a method for selecting anti-influenza virus antibody
12/23/2010WO2010146599A1 Process for purification of recombinant human granulocyte colony stimulating factor
12/23/2010WO2010146584A1 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
12/23/2010WO2010146359A1 Production of viral capsids
12/23/2010WO2010146094A1 Hla-g alpha 1 multimers and pharmaceutical uses thereof
12/23/2010WO2010146043A2 System for the heterologous expression of a viral protein in a ciliate host cell
12/23/2010WO2010145820A1 Cloning, yeast expression, purification and biological activity of the extension region of the soybean 7s globulin alfa' subunit involved in hep g2 cell cholesterol homeostasis
12/23/2010WO2010145819A1 Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7s globulin alfa' subunit involved in hep g2 cell cholesterol homeostasis
12/23/2010WO2010145125A1 Highly purified human menopausal gonadotropins, method for preparing and uses thereof
12/23/2010WO2010145000A1 Biomarker of sarcomas
12/23/2010WO2010144968A1 Casein derived protease inhibitory peptides
12/23/2010WO2010127324A3 Chimeric pdz domain-containing protein for viral detection
12/23/2010WO2010121268A3 Regulation of aging by modulation of mitochondrial function
12/23/2010WO2010095150A3 Nucleic acids of jatropha curcas and its applications
1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 2916